Literature DB >> 25891434

The Effect of Insurance Type on Patient Access to Knee Arthroplasty and Revision under the Affordable Care Act.

Chang-Yeon Kim1, Daniel H Wiznia1, Walter R Hsiang1, Richard R Pelker1.   

Abstract

This study evaluated access to knee arthroplasty and revision in 8 geographically representative states. Patients with Medicaid were significantly less likely to receive an appointment compared to patients with Medicare or BlueCross. However, patients with Medicaid had increased success at making an appointment in states with expanded Medicaid eligibility (37.7% vs 22.8%, P=0.011 for replacement, 42.6% vs 26.9%, P=0.091 for revision), although they experienced longer waiting periods (31.5 days vs 21.1 days, P=0.054 for replacement, 45.5 days vs 22.5 days, P=0.06 for revision). Higher Medicaid reimbursement also had a direct correlation with appointment success rate for Medicaid patients (OR=1.232, P=0.001 for replacement, OR=1.314, P=0.014 for revision).
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  health care access; knee revision; medicaid; patient Protection and Affordable Care Act; total knee arthroplasty

Mesh:

Year:  2015        PMID: 25891434     DOI: 10.1016/j.arth.2015.03.015

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  21 in total

1.  Spatial Accessibility of Primary Care in England: A Cross-Sectional Study Using a Floating Catchment Area Method.

Authors:  Jan Bauer; Ruth Müller; Dörthe Brüggmann; David A Groneberg
Journal:  Health Serv Res       Date:  2017-07-07       Impact factor: 3.402

2.  Influence of Medical Insurance Under the Affordable Care Act on Access to Pain Management of the Trauma Patient.

Authors:  Daniel H Wiznia; Theodore Zaki; Julianna Maisano; Chang-Yeon Kim; Thomas M Halaszynski; Michael P Leslie
Journal:  Reg Anesth Pain Med       Date:  2017 Jan/Feb       Impact factor: 6.288

3.  Does Medicaid Insurance Confer Adequate Access to Adult Orthopaedic Care in the Era of the Patient Protection and Affordable Care Act?

Authors:  Joseph T Labrum; Taylor Paziuk; Theresa C Rihn; Alan S Hilibrand; Alexander R Vaccaro; Mitchell G Maltenfort; Jeffrey A Rihn
Journal:  Clin Orthop Relat Res       Date:  2017-02-21       Impact factor: 4.176

4.  Two-State Comparison of Total Joint Arthroplasty Utilization Following Medicaid Expansion.

Authors:  Christopher J Dy; Derek S Brown; Hera Maryam; Matthew R Keller; Margaret A Olsen
Journal:  J Arthroplasty       Date:  2018-12-22       Impact factor: 4.757

5.  The impact of insurance coverage on access to orthopedic spine care.

Authors:  Dale N Segal; Zachary J Grabel; Weilong J Shi; Michael B Gottschalk; Scott D Boden
Journal:  J Spine Surg       Date:  2018-06

6.  Is There an Association Between Insurance Status and Survival and Treatment of Primary Bone and Extremity Soft-tissue Sarcomas? A SEER Database Study.

Authors:  Anne A Smartt; Eugene S Jang; Wakenda K Tyler
Journal:  Clin Orthop Relat Res       Date:  2020-03       Impact factor: 4.755

7.  Financial Distress Is Associated With Delay in Seeking Care for Hand Conditions.

Authors:  Thompson Zhuang; Sara L Eppler; Lauren M Shapiro; Allison K Roe; Jeffrey Yao; Robin N Kamal
Journal:  Hand (N Y)       Date:  2019-08-13

8.  Medicaid Payer Status Is a Predictor of Early Postoperative Pain Following Upper Extremity Procedures.

Authors:  Michael T Scott; Allison L Boden; Stephanie A Boden; Lauren M Boden; Kevin X Farley; Michael B Gottschalk
Journal:  Hand (N Y)       Date:  2020-04-01

Review 9.  Racial/Ethnic and Socioeconomic Disparities in Osteoarthritis Management.

Authors:  Angel M Reyes; Jeffrey N Katz
Journal:  Rheum Dis Clin North Am       Date:  2020-10-29       Impact factor: 2.670

10.  Musculoskeletal Urgent Care Centers in Connecticut Restrict Patients with Medicaid Insurance Based on Policy and Location.

Authors:  Daniel H Wiznia; Christopher A Schneble; Mary I O'Connor; Said A Ibrahim
Journal:  Clin Orthop Relat Res       Date:  2020-07       Impact factor: 4.755

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.